 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Stockwinners Market Radar for August 30, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
| TEM | Hot Stocks20:04 EDT Cathie Wood's ARK Investment bought 134K shares of Tempus AI today
|
| BAC BRK.A | Hot Stocks20:00 EDT Berkshire Hathaway sells another 21.1M Bank of America shares for $848M - In a regulatory filing, Berkshire Hathaway (BRK.A) disclosed that its sold another 21,076,473 shares of Bank of America (BAC) stock valued at $848.16M over the period of August 28 to August 30. The sale follows Bershire Hathaway disclosing that it sold 24.7M shares of the company for about $982M earlier this week. When Warren Buffett's Berkshire Hathaway disclosed in an SEC filing its holdings as of June 30, it had previously reported that the fund's top holdings as of June 30, in order of size, were Apple (AAPL), Bank of America (BAC), American Express (AXP), Coca-Cola (KO), and Chevron (CVX).
|
| ABIO | Hot Stocks19:50 EDT ARCA Biopharma trading halted, news pending
|
| HII | Hot Stocks17:21 EDT HII awarded $228.29M Navy contract modification - HII was awarded a $228.29M cost-plus-incentive-fee modification to a previously awarded contract for the DDG 1002 Combat System Availability, or CSA, and Mission Systems Activation, or MSA. Work is expected to be completed by April 2027. FY24 shipbuilding and conversion funds in the amount of $199.79M will be obligated at time of award and will not expire at the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity.
|
| GD | Hot Stocks17:19 EDT General Dynamics awarded $491.61M Air Force contract modification - General Dynamics has been awarded a $491.61M modification to a previously awarded contract for the Proliferated Warfighter Space Architecture Ground Management and Integration and operation and sustainment efforts. The modification brings the total cumulative face value of the contract to $887.8M from $396.19M. Work is expected to be completed by September 30, 2029. FY24 research, development, test and evaluation funds in the amount of $39.41M are being obligated at time of award. The Space Development Agency is the contracting activity.
|
| LMT | Hot Stocks17:15 EDT Lockheed Martin awarded $3.43B Army contract modification - Lockheed Martin was awarded a $3.43B modification to a contract for the Guided Multiple Launch Rocket System. Work locations and funding will be determined with each order, with an estimated completion date of October 20, 2027. U.S. Army Contracting Command is the contracting activity.
|
| AQU | Hot Stocks17:13 EDT Aquaron Acquisition receives delisting notification from Nasdaq - Aquaron Acquisition announced that it received a written notice from Nasdaq indicating that, because the company has not regained compliance with Listing Rule 5550(a)(3), which requires the company to have at least 300 public holders for continued listing on Nasdaq, trading of the company's common stock will be suspended at the opening of business on September 4 and a Form 25-NSE will be filed with the SEC, which will remove the company's securities from listing and registration on Nasdaq, unless the company requests a hearing to appeal this determination by 4:00 p.m. Eastern Time on September 4.
|
| BANF | Hot Stocks17:07 EDT BancFirst director Rainbolt sells over 18,000 common shares - In a regulatory filing, BancFirst director Leslie Jeannine Rainbolt disclosed the sale of 18,376.50 common shares of the company on August 30 at a price of $106.223 per share.
|
| SMCI | Hot Stocks17:04 EDT Supermicro Form 10-K to be filed within 15 day grace period - The subject annual report on Form 10-K will be filed on or before the fifteenth calendar day following the prescribed due date.
|
| RACE SAN | Hot Stocks17:00 EDT Ferrari announces termination of partnership with Santander - Ferrari (RACE) announced the termination of the partnership between Ferrari S.p.A., its wholly-owned subsidiary, and Santander (SAN), effective as of December 31, since the committed three-year contract will end. The partnership, which began in January 2022 after a previous collaboration from 2010 to 2017, saw Santander alongside the company in the sporting activities of the Prancing Horse. Santander has been a partner of Scuderia Ferrari in Formula 1 and has been its partner in the Le Mans Hypercar program.
|
| IFIN CURR | Hot Stocks16:52 EDT INFINT Acquisition, Seamless Group complete merger to become Currenc Group - Seamless Group and INFINT Acquisition Corporation (IFIN) announced the completion of the previously announced business combination. Beginning Tuesday, September 3, the combined company will operate as Currenc Group, and the ordinary shares will trade on The Nasdaq Stock Market under the ticker symbol "CURR."
|
| VSAC | Hot Stocks16:37 EDT Vision Sensing Acquisition extends period to enter business combination - Vision Sensing Acquisition, a special purpose acquisition company, announced that it has notified Continental Stock Transfer & Trust Company that it intends to extend the date by which the Company must consummate its initial business combination from September 3, 2024 to October 3, 2024, and that its sponsor, Vision Sensing, LLC, intends to deposit into the Company's trust account an aggregate of $51,016.10 by July 3, 2024. In connection with the Extension, the Company intends to issue to its sponsor a non-interest bearing, unsecured promissory note in the principal amount of $51,016.10 as consideration for the funding. This will be the fifth of up to six one-month extensions that the Company is authorized to obtain under its amended and restated certificate of incorporation as recently amended on April 30, 2024. The Extension provides the Company with additional time to complete an initial business combination.
|
| BFI | Hot Stocks16:32 EDT BurgerFi discloses Nasdaq listing deficiency notice - BurgerFi has received deficiency notices from Nasdaq Stock Market LLC related to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended July 1, 2024 and the composition of Board committees arising from the resignation of directors. On August 27, 2024, Nasdaq provided formal notice to the Company that as a result of the Company's failure to timely file its Q2 Form 10-Q, the Company does not comply with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listing Rule 5250(c)(1). Also on August 27, 2024, Nasdaq provided formal notice to the Company that as a result of the resignations of certain members of the Company's Board of Directors, the Company does not comply with Nasdaq's audit committee and compensation committee requirements set forth in Nasdaq Listing Rule 5605. The Company is required to submit to Nasdaq within 60 calendar days a plan to regain compliance with respect to the delinquent Q2 Form 10-Q, and if accepted by Nasdaq, the Company has until February 18, 2025 to implement the plan to regain compliance.
|
| CSX | Hot Stocks16:30 EDT CSX gets new 5-year tentative collective bargaining agreements with two unions - CSX announced it has secured new five-year tentative collective bargaining agreements with International Brotherhood of Boilermakers, Iron Ship Builders, Blacksmiths, Forgers & Helpers and the Transportation Communications Union. The tentative agreements, which are pending ratification by the unions' membership at CSX, were reached more than four months before the current collective agreements become amendable under the federal Railway Labor Act.
|
| ENS | Hot Stocks16:27 EDT EnerSys CEO Shaffer sells 17,600 common shares - In a regulatory filing, EnerSys president and CEO David Shaffer disclosed the sale of 17,600 common shares of the company on August 29 at a price of $100.08 per share.
|
| MSEX | Hot Stocks16:26 EDT Middlesex Water files for rate adjustment - Tidewater Utilities, a wholly owned subsidiary of Middlesex Water Company, filed a request with the Delaware Public Service Commission for new rates in order to recover prudently incurred investments made in the last ten years to support continued regulatory compliance, enhance water quality, service reliability, security and resiliency of its water utility infrastructure assets. Tidewater is seeking a total annual revenue increase of approximately $10.3 million. The rate request will be reviewed by the PSC and Division of the Public Advocate. If the rate increase request is approved in its entirety, the water bill for an average residential customer with usage of 5,000 gallons of water per month, would increase about $13.97 per month.
|
| SOI | Hot Stocks16:16 EDT Solaris Oilfield shareholders approve acquisition of Mobile Energy Rentals - Solaris Oilfield announced that all of the proposals related to its previously announced acquisition of Mobile Energy Rentals were approved by the requisite holders of Solaris common stock at the company's special meeting of stockholders. Pending the satisfaction of customary closing conditions, the company continues to expect the MER acquisition to close in September 2024.
|
| STEM | Hot Stocks16:15 EDT Stem receives continue listing standard notice from NYSE - Stem announced that, on August 28, 2024, it had received a written notice from the New York Stock Exchange that the average closing price of its shares of common stock had fallen below $1.00 per share over a period of 30 consecutive trading days, which is the minimum average closing price required to maintain continued listing on the NYSE. Stem will respond to the NYSE within 10 business days of receipt of the notice regarding its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. Under the NYSE's rules, the cure period extends for six months following receipt of the notice. The company's shares of common stock continue to trade on the NYSE, subject to compliance with other continued listing requirements. Under the NYSE's rules, Stem can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period, its common stock has a closing share price of at least $1.00 per share and an average closing price of at least $1.00 per share over the 30-trading-day period ending on the last trading day of such month. Failure to satisfy the conditions of the cure period or to maintain other listing requirements could lead to a delisting. The NYSE's notice does not affect Stem's business operations or its reporting obligations with the SEC, and does not conflict with or cause an event of default under any of Stem's material debt or other agreements.
|
| SMCI | Hot Stocks16:10 EDT Supermicro to delay filing Annual Report on Form 10-K - Super Micro Computer is unable to file its Annual Report on Form 10-K for the period ended June 30, 2024 in a timely manner without unreasonable effort or expense. In response to information that was brought to the attention of the Audit Committee of the company's Board of Directors, the Board of Directors has formed a committee to review certain of the company's internal controls and other matters. The Review is ongoing and all parties are working diligently to complete the Review. Additional time is also needed for the company's management to complete its assessment of the effectiveness of its internal controls over financial reporting as of June 30, 2024. Based upon the work done to date, the company does not anticipate the 2024 Form 10-K will contain any material changes to its results for the fiscal year and quarter ended June 30, 2024 that were announced in the company's press release dated August 6, 2024. As a result of the foregoing, the company needs additional time to finalize its financial statements and related disclosures to be filed as part of the 2024 Form 10-K.
|
| IOBT MRK | Hot Stocks16:06 EDT IO Biotech says IDMC recommends continuation of IO102-IO103 trial - IO Biotech (IOBT) announced that an Independent Data Monitoring Committee recommended continuation of the company's pivotal Phase 3 trial of its lead investigational therapeutic vaccine, IO102-IO103, following a per-protocol interim analysis. The trial is evaluating IO102-IO103 in combination with KEYTRUDA, Merck's (MRK) anti-PD-1 therapy, as a first-line treatment for patients with unresectable or metastatic melanoma. Based on their review of the safety and efficacy data, the IDMC recommended that the trial continue without modifications and noted that no new safety signals were observed. The primary endpoint of progression-free survival is projected to be reached in the first half of 2025. The per-protocol interim analysis was performed one year after 225 patients were randomized in the trial. The interim efficacy analysis was intentionally set with a high statistical bar, and based on the analysis, the IDMC determined that the data did not meet the criteria to declare superiority of ORR. The trial was designed to preserve most of the statistical alpha for the trial's primary endpoint of PFS. The PFS analysis is event-driven and will be conducted when 226 events have been reported in the trial with independent central review. With 407 patients randomized, the trial is powered at 89% to detect a 35% reduction in the risk of an event. "To date, none of the approved immunotherapeutic combinations for the treatment of advanced melanoma demonstrated statistical significance in ORR in large Phase 3 trials; nevertheless, these trials achieved statistical significance on PFS," said Mai-Britt Zocca, PhD, President and CEO of IO Biotech. "Based on the 25.5 months median PFS we observed in the Phase 1/2 trial of IO102-IO103 in combination with a PD-1 inhibitor in advanced melanoma, with no added significant systemic toxicity than that typically seen with anti-PD-1 monotherapy, we remain optimistic about meeting the primary endpoint of PFS, projected to occur in the first half of 2025."
|
| DO NE | Hot Stocks16:02 EDT Diamond Offshore, Noble Corp. transaction expected to close on September 4 - Noble (NE) and Diamond Offshore Drilling (DO) announced the receipt of clearance from the Australia Competition & Consumer Commission, in relation to the pending transaction between Noble and Diamond Offshore, which is the final required regulatory approval for the transaction. The parties expect to close the transaction on Wednesday September 4th.
|
| PFBC | Hot Stocks16:02 EDT Preferred Bank receives regulatory approval to continue $150M stock buyback - Preferred Bank announced that the Bank has received regulatory approval to continue its shareholder-approved $150M stock Repurchase Plan. Thus far in the Plan, the Bank has repurchased $72.5M of its common stock over the latter half of 2023 and into 2024, however regulatory approval expired in July of 2024. As a state, non-member Bank that issues its common stock at the Bank level, Preferred Bank is required to seek regulatory approval to engage in transactions that either increase or decrease capital. This approval to repurchase the remaining $77.5M of common stock will expire in February of 2025 and purchases will be made in the open market. The first portion of this repurchase totaled $72.5M at an average price of $62.02.
|
| NVAX | Hot Stocks15:49 EDT Novavax says FDA gives updated COVID vaccine emergency use authorization - Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted has received Emergency Use Authorization from the U.S. Food and Drug Administration for active immunization to prevent COVID-19 in individuals aged 12 and older. Novavax's vaccine is included in the recommendations issued by the U.S. Centers for Disease Control and Prevention on June 27, 2024. Pre-filled syringes of the vaccine will be available in thousands of locations, including retail and independent pharmacies and regional grocers, following the Center for Biologics Evaluation and Research release of vaccine batches. "Today's authorization enables Novavax to launch our updated COVID-19 vaccine in the U.S. in pre-filled syringes, and we have worked hard to ensure consumers have access in thousands of locations nationwide," said John C. Jacobs, President and Chief Executive Officer, Novavax. "Our updated vaccine targets JN.1, the 'parent strain' of currently circulating variants, and has shown robust cross-reactivity against JN.1 lineage viruses, including KP.2.3, KP.3, KP.3.1.1 and LB.1."
|
| CMPR | Hot Stocks14:39 EDT Cimpress CFO Quinn sells $2.37M of shares - Cimpress CFO Sean Edward Quinn disclosed the sale of 24,093 shares at an average price of $94.48 for a total of $2.37M.
|
| IFIN | Hot Stocks14:32 EDT InFintT Acquisition Corp trading resumes
|
| NVAX | Hot Stocks14:29 EDT FDA grants emergency use to updated Novavax COVID vaccine - The Food and Drug Administration granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine "that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death" The updated vaccine is authorized for use in individuals 12 years of age and older. It includes a monovalent component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2, the FDA said in a statement. Reference Link
|
| IFIN | Hot Stocks14:26 EDT InFintT Acquisition Corp trading halted, volatility trading pause
|
| STLA | Hot Stocks13:14 EDT Chrysler heir proposes to buy Chrysler, Dodge brands from Stellantis - Frank B. Rhodes, Jr. the great-grandson of Walter P. Chrysler, has sent a proposal to Stellantis, N.V., and its CEO, Carlos Tavares and announced his desire to acquire the Chrysler/Dodge brands, it was announced earlier. Rhodes said, "I believe that my plan would allow Stellantis a graceful exit from a brand that in my opinion it has no interest in keeping, and has been steadily killing off its brands. I would like to see jobs saved, and increased, and the Iconic Brands reinvigorated, and to see a true proud American ownership, that retains this American Icon where it belongs and not in the control of people who do not understand our strong feelings about continuing the 100-year legacy of true American auto pioneer Brands. I asked Mr. Tavares to schedule a confidential discussion to outline my plan, and I am certain that it would be of interest to all parties especially to the long-time terminated employees, the creative and marketing staff and loyal Brand owners who have been anxious to see this historical iconic brand brought back to life as part of Chrysler's 2025 rebirth, a plan I am calling the 'CHRYSLER 2025 COMEBACK' creating new high paying Union jobs with exciting automobile concepts that never materialized under that much touted UNLEASHING of the Brand's potential under the direction of Ms. Feuell, as Brand CEO." In a statement in response, Stellantis acknowledged the interest in its North American brands and reaffirmed "the company's commitment to its entire portfolio of 14 powerful, iconic brands, which were each given a 10-year timeframe to build a profitable and sustainable business," adding that the company is "not pursuing splitting off any of its brands." Reference Link
|
| STLA | Hot Stocks13:06 EDT Stellantis says 'not pursuing splitting off any of its brands' - Stellantis issued the following statement in response to proposal to sell Chrysler and Dodge brands: "Stellantis acknowledges the interest in its North American brands and reaffirms the company's commitment to its entire portfolio of 14 powerful, iconic brands, which were each given a 10-year timeframe to build a profitable and sustainable business. Like the Jeep and Ram brands, Chrysler and Dodge are at the forefront of Stellantis' transformation to clean mobility, benefitting from the Group's cutting-edge technology and scale. The company is not pursuing splitting off any of its brands." Reference Link
|
| JBDI | Hot Stocks13:05 EDT JBDI Holdings Ltd trading resumes
|
| BKR | Hot Stocks13:01 EDT Baker Hughes reports U.S. rig count down 2 to 583 rigs - Baker Hughes reports the U.S. rig count is down 2 from last week to 583, with oil rigs unchanged at 483, gas rigs down 2 to 95 and miscellaneous rigs unchanged at 5. The U.S. rig count is down 48 rigs from last year's count of 631, with oil rigs down 29, gas rigs down 19 and miscellaneous rigs unchanged. The U.S. offshore rig count is unchanged at 19, up 2 year-over-year.
|
| JBDI | Hot Stocks12:55 EDT JBDI Holdings Ltd trading halted, volatility trading pause
|
| ISENF | Hot Stocks12:04 EDT Isoenergy president Tim Gabruch resigns - IsoEnergy announces that Tim Gabruch, President of the Company has resigned from his position effective August 31, 2024, to pursue other opportunities.
|
| SKIL | Hot Stocks12:00 EDT Skillsoft rises 7.3% - Skillsoft is up 7.3%, or $1.06 to $15.57.
|
| CLCO | Hot Stocks12:00 EDT Cool Company rises 8.0% - Cool Company is up 8.0%, or 88c to $11.88.
|
| GWH | Hot Stocks12:00 EDT ESS Tech rises 9.2% - ESS Tech is up 9.2%, or 63c to $7.51.
|
| EE | Hot Stocks12:00 EDT Excelerate Energy falls -7.3% - Excelerate Energy is down -7.3%, or -$1.43 to $18.15.
|
| FEDU | Hot Stocks12:00 EDT Four Seasons Education falls -8.7% - Four Seasons Education is down -8.7%, or -$1.71 to $17.98.
|
| ESTC | Hot Stocks12:00 EDT Elastic falls -27.3% - Elastic is down -27.3%, or -$28.27 to $75.37.
|
| GEV | Hot Stocks11:36 EDT Dogger Bank says GE Vernova blade event not caused by manufacturing issue - Dogger Bank, a joint venture partnership between SSE Renewables, Equinor and Vargronn, stated in a project update posted to its website: "Following the blade event on 22 August on an installed turbine at the Dogger Bank A offshore wind farm construction site, Dogger Bank Wind Farm has been working closely with turbine manufacturer, GE Vernova, to investigate the root cause of the event. GE Vernova analysis has shown that this blade event was not caused by an installation or manufacturing issue but instead occurred during the commissioning process. GE Vernova analysis has established that during the commissioning process being performed by GE Vernova, the turbine was left in a fixed and static position, rendering it vulnerable during a subsequent storm with high winds. The surrounding marine area at the site remains restricted in line with safety procedures. Installation activities at the site will restart in the coming days." Reference Link
|
| BBIO BAYRY | Hot Stocks10:53 EDT BridgeBio presented additional data from an analysis of acoramidis studies - BridgeBio Pharma (BBIO) announced it presented additional data from an analysis of its Phase 3 ATTRibute-CM and open-label extension study of acoramidis in ATTR-CM at the European Society of Cardiology, or ESC, 2024. ATTRibute-CM was designed to study the efficacy and safety of acoramidis, an investigational, next-generation, orally-administered, highly potent, small molecule stabilizer of TTR. The data on change from baseline in serum TTR levels in participants receiving acoramidis versus those receiving tafamidis in the placebo group in ATTRibute-CM at Month 30, as well as serum TTR levels in patients who transitioned from placebo and tafamidis to acoramidis in the OLE study, were presented by Mathew Maurer, M.D. of Columbia University Irving Medical Center. In participants who switched from tafamidis and placebo in the ATTRibute-CM study to acoramidis in its OLE, there was a mean of 3.0mg/dL increase in serum TTR at Month 1 of the OLE and mean of 3.4mg/dL increase in serum TTR at Month 6 of the OLE. Based on the positive results from ATTRibute-CM, BridgeBio submitted a New Drug Application to the U.S. Food and Drug Administration, which has been accepted with a PDUFA action date of November 29, 2024, and a Marketing Authorization Application to the European Medicines Agency, with a decision expected in 2025. BridgeBio has granted exclusive rights to Bayer (BAYRY) to commercialize acoramidis for ATTR-CM in Europe.
|
| KEY BNS | Hot Stocks10:20 EDT KeyCorp, Scotiabank complete initial tranche of strategic minority investment - KeyCorp (KEY) announced that The Bank of Nova Scotia (BNS), or "Scotiabank," has completed the initial purchase of KeyCorp's common stock with an investment of approximately $0.8B as expected. With this investment, Scotiabank now owns approximately 4.9% of KeyCorp's common stock. This initial purchase is part of the agreement announced on August 12, under which Scotiabank will make a strategic minority investment in KeyCorp of approximately $2.8B, representing approximately 14.9% pro forma common stock ownership, for a fixed price of $17.17 per share. The parties expect to complete the final purchase of approximately $2.0B upon receipt of Federal Reserve approval, which is expected to occur in the first quarter of 2025.
|
| NCNA | Hot Stocks10:15 EDT NuCana PLC (ADR) trading resumes
|
| YXT | Hot Stocks10:06 EDT YXT.Com Group Holding Ltd - ADR trading resumes
|
| YXT | Hot Stocks10:01 EDT YXT.Com Group Holding Ltd - ADR trading halted, volatility trading pause
|
| TALO | Hot Stocks10:00 EDT Talos Energy falls -6.8% - Talos Energy is down -6.8%, or -81c to $11.13.
|
| FEDU | Hot Stocks10:00 EDT Four Seasons Education falls -8.6% - Four Seasons Education is down -8.6%, or -$1.69 to $18.00.
|
| ESTC | Hot Stocks10:00 EDT Elastic falls -26.7% - Elastic is down -26.7%, or -$27.62 to $76.02.
|
| CLCO | Hot Stocks10:00 EDT Cool Company rises 7.7% - Cool Company is up 7.7%, or 85c to $11.85.
|
| MNSO | Hot Stocks10:00 EDT Miniso rises 8.0% - Miniso is up 8.0%, or $1.31 to $17.63.
|
| ZK | Hot Stocks10:00 EDT Zeekr rises 10.1% - Zeekr is up 10.1%, or $1.64 to $17.84.
|
| TALO | Hot Stocks09:59 EDT Talos Energy reaffirms Q3 production guidance, FY24 guidance - In conjunction with Talos Energy having announced that Tim Duncan has stepped down from his role as President and Chief Executive Officer, effective August 29, Talos reaffirms its third quarter 2024 production guidance and operational and financial guidance for the full year 2024. As previously reported, for the third quarter 2024, Talos expects average daily production of 92.0 - 97.0 thousand barrels of oil equivalent per day.
|
| TALO | Hot Stocks09:57 EDT Talos Energy announces Tim Duncan stepped down as CEO - Earlier, Talos Energy announced that Tim Duncan has stepped down from his role as President and Chief Executive Officer, effective August 29. Joseph Mills, who has served on the company's board since March, 2024, will serve as interim President and Chief Executive Officer until a successor is in place. The company's board of directors has initiated a search for a successor in partnership with a leading executive search firm. "I'm honored to step in as interim CEO of Talos," said Mills. "The Board has played an active role guiding and evaluating our strategic approach, and I am confident about Talos's direction and strategy. Our commitment remains firm in delivering compelling value for our shareholders. I look forward to working closely with the Board and leadership team, drawing on their extensive knowledge to advance our strategic priorities during this transitional period."
|
| FEDU | Hot Stocks09:48 EDT Four Seasons Education falls -8.6% - Four Seasons Education is down -8.6%, or -$1.69 to $18.00.
|
| TALO | Hot Stocks09:48 EDT Talos Energy falls -9.0% - Talos Energy is down -9.0%, or -$1.08 to $10.86.
|
| ESTC | Hot Stocks09:47 EDT Elastic falls -24.9% - Elastic is down -24.9%, or -$25.84 to $77.80.
|
| ZK | Hot Stocks09:47 EDT Zeekr rises 6.6% - Zeekr is up 6.6%, or $1.07 to $17.27.
|
| MNSO | Hot Stocks09:47 EDT Miniso rises 7.0% - Miniso is up 7.0%, or $1.14 to $17.46.
|
| EBS | Hot Stocks09:47 EDT Emergent BioSolutions rises 11.6% - Emergent BioSolutions is up 11.6%, or $1.03 to $9.95.
|
| TCBP | Hot Stocks09:38 EDT TC Biopharm (Holdings) PLC - ADR trading resumes
|
| HBM | Hot Stocks09:33 EDT Hudbay Minerals receives Aquifer Protection Permit for Copper World project - Hudbay Minerals has received an Aquifer Protection Permit for the Copper World project. from the Arizona Department of Environmental Quality. The company proactively engaged with the ADEQ, ensuring a transparent and thorough permitting process by providing comprehensive and detailed information. The issuance of this permit is a key milestone in the advancement of Copper World, which is a standalone operation requiring state and local permits and is expected to produce 85,000 tonnes of copper per year over a 20-year mine life . Once in production, Copper World is expected to be a meaningful copper producer in the U.S. domestic copper supply chain, which will be required to help secure growing U.S. metal demand related to increased manufacturing capacity, infrastructure development, increased energy independence and domestic battery supply chain and production needs. The "Made-in-America" copper cathode anticipated to be produced at Copper World is expected to be sold entirely to domestic U.S. customers and would make Copper World the third largest cathode producer in the U.S. There are three key state permits required for Copper World sanctioning: Mined Land Reclamation Plan - Completed - the Mined Land Reclamation Plan was initially approved by the Arizona State Mine Inspector in October 2021 and was subsequently amended and approved to reflect a larger private land project footprint. This approval was challenged in state court, but the challenge was dismissed in May 2023. Aquifer Protection Permit - Completed - the Aquifer Protection Permit was received on August 29, 2024 from the ADEQ following a robust process that included detailed analysis by the agency and Hudbay, along with a public comment period that was completed in the second quarter of 2024. Air Quality Permit - On Track - the Air Quality Permit application was submitted to the ADEQ in late 2022 and follows a similar robust process, including a public comment period that commenced in July and is scheduled to conclude in September 2024.
|
| TCBP | Hot Stocks09:33 EDT TC Biopharm (Holdings) PLC - ADR trading halted, volatility trading pause
|
| NCNA | Hot Stocks09:30 EDT NuCana PLC (ADR) trading halted, volatility trading pause
|
| DPMLF | Hot Stocks09:14 EDT Dundee Precious Metals completes sale of Tsumeb smelter - Dundee Precious Metals announced the closing of the sale of the Tsumeb smelter to a subsidiary of Sinomine Resource Group. The purchase price for the sale of the Tsumeb smelter was $20M, on a debt-free and cash-free basis, less a $5M holdback to be held in escrow for a period of six months to secure the Company's indemnity obligations under the share purchase agreement with Sinomine. Total cash consideration paid on closing was $15.9M, as adjusted, less the escrow holdback amount. The cash consideration is subject to normal post-closing adjustments.
|
| ATPC | Hot Stocks09:05 EDT Agape ATP addresses recent corporate exercise, strategic developments - AGAPE ATP announced a series of significant updates reflecting its ongoing commitment to growth and sustainability. Effective today, ATPC will implement a 1-for-20 reverse stock split of its shares of common stock, as previously disclosed in filings with the Securities and Exchange Commission. This strategic action aims to increase the market price per share, thereby meeting NASDAQ's continued listing standards and ensuring the Company's position on a globally recognized exchange. Additionally, the number of authorised shares of common stock will be reduced from 1,000,000,000 to 50,000,000. Beyond the reverse stock split, ATPC is advancing several strategic initiatives aimed at strengthening its position and providing value to shareholders. The Company is planning to launch new products expected to enhance its financial outlook and market presence. The recent partnership with B&H Intec Solution Sdn. Bhd, which led to the formation of ATPC Green Energy Sdn. Bhd., has lined up a promising pipeline in its green energy sector. This venture is an important step in expanding the Company's capabilities in sustainable energy solutions, aligning with its broader goals of supporting environmental sustainability. Furthermore, ATPC is actively expanding its offerings in the wellness and senior care sectors. Cedar ATPC Sdn. Bhd. is poised to introduce a range of new wellness services designed to meet the growing demand for health and wellness solutions. At the same time, Sweet Home Senior Living Care Centre Sdn Bhd continues to thrive, delivering high-quality care services to address the needs of an aging population. These initiatives underscore the Company's commitment to enhancing the quality of life and supporting sustainable development, which are core pillars of its business strategy. Financially, the Company remains on solid footing, with a strong balance sheet and sufficient liquidity to support ongoing and future initiatives. ATPC is also exploring new opportunities in both domestic and regional markets, particularly in the areas of Wellness and Green Energy, as part of its strategy for sustainable growth. The Company recognises the concerns of its investors regarding the reverse stock split and wants to assure them that these actions are part of a broader strategy to ensure long-term stability and growth. While short-term market dynamics can be influenced by various factors, including geopolitical events and economic shifts, ATPC is confident in the underlying strength of the markets in which it operates and its strategic positioning within them. The management team is closely monitoring market conditions and remains prepared to take swift, decisive actions to protect and enhance shareholder value.
|
| AMPG | Hot Stocks09:04 EDT AmpliTech Group's bookings surpass $1M in August - AmpliTech Group announced surpassing bookings in excess of $1M as result of increased quoting activity experienced since the start of Q3 2024. AmpliTech Group is pleased to see the level of bookings achieved this month across its divisions, with Spectrum Semiconductor Materials Division booking a single order in excess of $600K, from a new domestic customer this month and Specialty Microwave Division booking an order from Paramount in excess of $200K. As recently announced, the company expects its AGTGSS to start announcing within the next few weeks, initial wins in regards their Private 5G product line.
|
| NSC | Hot Stocks09:03 EDT Norfolk Southern reaches tentative bargaining agreements with five labor unions - Norfolk Southern is proud to announce it has reached tentative, five-year collective bargaining agreements with five labor unions in addition to the four announced last week. These nine agreements, which, together, cover approximately 55% of the company's unionized workforce, come four months before the opening of the next collective bargaining round, underscoring Norfolk Southern's commitment to provide prompt, meaningful enhancements to pay, health care, and time off for its dedicated craft railroaders. The most recent agreements, which were reached in partnership with BNSF Railway and are subject to ratification, include the International Brotherhood of Boilermakers and Blacksmiths and the National Conference of Firemen and Oilers. Norfolk Southern also separately reached tentative agreements with the American Train Dispatchers Association, the Brotherhood of Maintenance of Way Employes Division, and the International Association of Sheet Metal, Air, Rail and Transportation Workers - Transportation Division Yardmasters.
|
| SCLX | Hot Stocks09:02 EDT Scilex to present on ZTlido at 2024 Annual PAINWeek Conference - Scilex Holding Company announced oral, poster presentations, and symposia on ZTlido at the 2024 Annual PAINWeek conference in Las Vegas, NV on September 3-5, 2024. Key highlights of the ZTlido 1.8% presentation: September 4, 2024; NON-CME Presentation in the Castellana Ballroom. 12:00PM PT - 1:00PM PT; TITLE: What to do when pain relief with Gabapentinoids isn't enough? DESCRIPTION: Gabapentinoids are the foundational analgesics used to treat neuropathic pain of PHN, and their usage has grown rapidly in recent years given increasing scrutiny around opioid prescribing. The unmet need, though, remains high, given the challenges with titrating them to an effective dose. Dr Charles Argoff will review what analgesic options exist to optimize gabapentinoids, and the trade-offs that come with different agents. Dr. Argoff is Professor of Neurology and Director of the Comprehensive Pain Program at Albany Medical Center in New York. He is an internationally renowned for his work in Pain Management - in research, teaching and patient care, and serves as the President of AAPM/ September 5, 2024: 5:50PM PT - 6:00PM PT: Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis to be Presented by Srinivas Nalamachu, M.D. 6:05PM PT - 6:15PM PT: Decreased Cost Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis to be Presented by Srinivas Nalamachu, M.D.
|
| BIRD | Hot Stocks09:02 EDT Allbirds announces 1-for-20 reverse stock split - Allbirds announced that it will proceed with a 1-for-20 reverse stock split of its outstanding shares of Class A Common Stock and Class B Common Stock following approval by its Board of Directors. The 1-for-20 ratio is within the range approved by stockholders at a special meeting of BIRD stockholders held on August 13, 2024.
|
| CCK | Hot Stocks08:58 EDT Crown Holdings to transfer $740M in U.S pension plan obligations - Crown Holdings announced that it has entered into an agreement to purchase a group annuity contract from Massachusetts Mutual Life Insurance Company to fully guarantee benefits covered under the contract for nearly all of the retirees and deferred vested participants in its primary US defined benefit plans. The transaction provides a policy which covers the benefits for approximately 12,000 participants. MassMutual will make payments to participants starting November 1, 2024. Benefits payable to the retirees and other plan participants will not be affected by the transaction. The company expects to contribute approximately $100M to the plan and to record a one-time non-cash charge of approximately $450M ($340M after tax) in the third quarter of 2024 as a part of the plan settlement. The company reaffirms its previously provided 2024 full year adjusted free cash flow guidance of at least $750M.
|
| SAI | Hot Stocks08:31 EDT SAITECH joins World Nuclear Association - SAI.TECH announces its membership in the World Nuclear Association. As a member of WNA, SAI's CEO Arthur Lee, and the Company's Nuclear Energy Strategy Consultant Francois Morin, will present in World Nuclear Symposium 2024 this September. As a new member, SAI will promote best practices with HEATNUC Gen. III and Gen. IV small modular reactors in the World Nuclear Symposium 2024. The symposium, organized by the WNA, is a premier event for industry professionals to discuss the latest advancements, challenges, and opportunities within the nuclear sector. This move reflects with SAI's commitment to advancing the nuclear industry through collaboration and innovation. As a member of the WNA, SAI will engage with a global network of industry leaders, experts, and governers dedicated to the sustainable development and promotion of nuclear power.
|
| EBS | Hot Stocks08:19 EDT Emergent BioSolutions kicks off second year of Ready to Rescue initiative - Emergent BioSolutions announced it is kicking off the second year of the Ready to Rescue initiative, which will include new college football tailgate stops, in-stadium activities, Greek Life events and student wellness clinics. As part of these expanded efforts, pro football legend and campaign spokesperson, Emmitt Smith, will continue to share his story to raise awareness of opioid risks and inspire students, parents, faculty and alumni to be prepared to save a life with NARCAN Nasal Spray, which is available over-the-counter
|
| CLBT | Hot Stocks08:08 EDT Cellebrite announces 'Redemption Fair Market Value' - Cellebrite DI announced the "Redemption Fair Market Value" in connection with its previously announced redemption of its warrants to purchase ordinary shares of the Company. On August 15, 2024, the Company announced that it will redeem all of its Warrants that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 for a redemption price of $0.10 per Warrant. Warrant holders may elect to exercise their Warrants for cash or on a "cashless basis" before 5:00 p.m. New York City time on the Redemption Date, subject to the terms of the Company's previously issued notice of redemption. The "Redemption Fair Market Value" announced today is used to determine the number of Ordinary Shares that will be issued to Warrant holders who exercise their warrants on a "cashless basis". Based on the Redemption Fair Market Value, Warrant holders who exercise their Warrants by surrendering them pursuant to a Make-Whole Exercise prior to the Redemption Date will receive 0.342 Ordinary Shares per Warrant.
|
| VTYX | Hot Stocks08:05 EDT Ventyx Biosciences announces departure of CFO Auster - Ventyx Biosciences announced that Martin Auster, M.D. has departed from his role as Chief Financial Officer, effective August 30, 2024. Roy Gonzales, CPA, MBA, the Company's SVP of Finance, has assumed the roles of interim Principal Financial Officer and interim Principal Accounting Officer for SEC reporting purposes. The company has initiated a search for a CFO.
|
| DHAI | Hot Stocks08:05 EDT DIH appoints HNRC as DIH Center of Excellence - DIH Holding US announced that Haapsalu Neurological Rehabilitation Center, located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation Center is now the first such center in the Baltics Region. The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robotics while demonstrating how DIH therapy solutions contribute to successful patient outcomes. These Centers also contribute to the development of advanced rehabilitation technologies.
|
| QOMO | Hot Stocks08:05 EDT Qomolangma Acquisition announces receipt of notice from Nasdaq - Qomolangma Acquisition announced that it has received a notice from The Nasdaq Stock Market stating that because the Company has not yet filed its Form 10-Q for the period ended June 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. This notification has no immediate effect on the listing of the Company's shares on Nasdaq. However, if the Company fails to timely regain compliance with the Nasdaq Listing Rule, the Company's common stock will be subject to delisting from Nasdaq.
|
| VXRT | Hot Stocks08:03 EDT Vaxart reports inducement grants under Nasdaq listing rule - Vaxart announced that on August 26, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 32,250 shares of its common stock to two new non-executive employees to induce them to accept employment with Vaxart. The awards consisted of stock options to purchase an aggregate of 21,500 shares of Vaxart's common stock, which vest as to 1/4th of the total shares on the one-year anniversary of the grant date, and as to 1/48th of the total shares on each month thereafter, and have a per share exercise price equal to the closing price of Vaxart's common stock on the grant date; and restricted stock unit awards covering an aggregate of 10,750 shares of Vaxart's common stock, which vest as to 25% of the shares underlying the awards on the first, second, third and fourth anniversary of the grant date.
|
| HOOK GMAB | Hot Stocks08:03 EDT Hookipa Pharma appoints O'Neill as non-executive chair of board - HOOKIPA Pharma (HOOK) announced the appointment of Director Julie O'Neill as Non-Executive Chair of the Company's Board of Directors. She succeeds Jan van de Winkel, who has decided to step down from the Board effective August 30, 2024, due to increasing time commitments from his executive position as Chief Executive Officer of Genmab (GMAB). The Company also announced that Tim Reilly has chosen to step down from the Board, also effective August 30th, to be able to dedicate more time to his other professional responsibilities.
|
| GNTX | Hot Stocks08:02 EDT Gentex announces Q3 cash dividend 12c - Gentex Corporation announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable October 23, 2024, to shareholders of record of the common stock at the close of business on October 9, 2024.
|
| QNTM | Hot Stocks07:37 EDT Quantum Group says Celly Nutrition launches unbuzzed stick packs on Amazon - Quantum BioPharma announces that launch of unbuzzd, a groundbreaking product designed to help individuals recover from the adverse effects of alcohol consumption and prepare for what's next. unbuzzd Clear Eyed Citrus Powder Sticks are now available on Amazon.com. On August 29, 2024, Celly Nutrition which is backed by the pharmaceutical research & development team at Quantum BioPharma, announced the launch.
|
| AVCNF | Hot Stocks07:35 EDT Avicanna announces repayment of debentures - Avicanna has cleared and fully repaid $1,445,000 that was owed under the Debentures of August 2 2023.
|
| ELBM | Hot Stocks07:31 EDT Electra to discuss opportunities at Indonesian Critical Minerals Summit - Electra Battery Materials announced its participation in Indonesia's first critical minerals conference, Fastmarket's International Critical Minerals and Metals Summit: Indonesia. The summit will bring together industry leaders, policymakers, and stakeholders to discuss Indonesia's role in the global energy transition. Electra's participation will underscore the opportunities to develop sustainable nickel and cobalt supply chains for the North American battery materials sector. Electra CEO, Trent Mell, will sit on a panel titled "Examining Indonesia's Role in Building an IRA-Compliant Supply Chain." The conversation will delve into Indonesia's expanding role as a key source of nickel and cobalt and how to build an EV supply chain that meets the requirements of the U.S. Inflation Reduction Act. As electric vehicle market share continues to expand, Indonesia's strategic importance in the global supply chain is poised to grow significantly. Electra's involvement in this conference is timely, following its recent announcement of a $20M Department of Defense grantaimed at advancing domestic cobalt refining capabilities. This grant marks a significant milestone in Electra's broader strategy to enhance the resilience of the North American battery minerals supply chain and diversify away from heavy reliance on Chinese processors.
|
| BABA | Hot Stocks07:31 EDT Alibaba praised by China's market regulator as antitrust review ends, SCMP says - China's State Administration for Market Regulation, or SAMR, the nation's market watchdog, praised Alibaba for its compliance with the antitrust authority as it put an official end to more than three years of regulatory scrutiny and closed out its antitrust review of Alibaba Group, reported the South China Morning Post, which notes it is owned by Alibaba. SAMR has given the group full recognition after fining the e-commerce giant $2.8B in 2021, "giving a big nod of approval to the Jack Ma-founded business empire just days before its Hong Kong stock is made available to mainland investors," the report added. Alibaba shares trading in New York are up $3.68, or nearly 5%, to $84.70 in the pre-market session. Reference Link
|
| DPRO | Hot Stocks07:16 EDT Draganfly confirms post-consolidation trading date - Draganfly announces that further to the news release issued August 23, 2024, the Company has set September 5, 2024 as the effective date of the Consolidation. The Company expects its issued and outstanding common shares to trade on a post-consolidated basis at market open on September 5, 2024 subject to final confirmation from the Canadian Securities Exchange and the Nasdaq. As announced on August 23, 2024, the board of directors of the Company approved the consolidation of its Common Shares on the basis of one post-consolidated Common Share for every 25 pre-consolidated Common Shares. Upon completion of the Consolidation, the CUSIP and ISIN of the Common Shares will be changed to 26142Q304 and CA26142Q3044 respectively.
|
| LAC GM | Hot Stocks07:08 EDT Lithium Americas provides update on General Motors investment - Lithium Americas (LAC) announced the company and General Motors (GM) have agreed to extend the outside date for the second tranche subscription agreement until the end of the year. Along with the extension, GM has reaffirmed its intention to complete the additional $330M investment to support development of Thacker Pass, which is the largest known Measured and Indicated lithium resource in North America. The company said, "During this time, the parties will explore alternative structures for GM's additional investment in a mutually beneficial manner. As such, the Company has agreed to forbear making a unilateral election to close the second tranche investment until December 20, 2024, to provide time for such discussions to take place. GM's investment is subject to the conditions precedent set forth in the second tranche subscription agreement, including the execution of the loan agreement for the $2.26 billion loan from the U.S. Department of Energy ("DOE") under the Advanced Technology Vehicles Manufacturing ("ATVM") Loan Program for which the DOE provided a conditional commitment (the "DOE Loan"). The unilateral election of the Company to close the second tranche investment after December 20, 2024, must be accompanied by the grant to GM of additional rights related to Phase 21 of Thacker Pass. The Company continues to work closely with the DOE and expects to close the DOE Loan and additional GM investment by the end of the year."
|
| PBM | Hot Stocks07:03 EDT Psyence Biomedical announces registration statement for equity line of credit - Psyence Biomedical announced that the registration statement pertaining to its previously announced $25M equity line of credit with White Lion Capital on Form F-1 has been declared effective by the U.S. Securities and Exchange Commission on August 28, 2024. As previously disclosed, this 24-month arrangement allows Psyence Biomed to sell up to $25M in shares to White Lion, subject to certain conditions.
|
| LOT | Hot Stocks07:02 EDT Lotus obtains local homologation certification for Eletre, Emeya in GCC region - Lotus Technology has recently obtained local homologation certification for the Eletre model and the Emeya model in the GCC region, paving the way for deliveries of Eletre started in the third quarter. The milestone marks an important step as the Company continues to expand its presence in a region renowned for its passion for heritage luxury brands of automobile, racing DNA, and advanced technologies. While deliveries of Eletre model are on the way, reservations of Emeya models also began. New Lotus showrooms and stores in prime locations across major cities will be available for customers to test-drive and experience the exceptional control and driving dynamics of Lotus vehicles, which embody optional advanced intelligent driving software. Bespoke service will also be available for personalization and customization, catering to reservations for limited-edition models.
|
| JKS | Hot Stocks06:37 EDT JinkoSolar sees Q3 module shipments 23-25 GW - The company said, "For the third quarter of 2024, the Company expects its module shipments to be in the range of 23.0 GW to 25.0 GW. For full year 2024, the Company estimates its module shipments to be in the range of 100.0 GW to 110.0 GW."
|
| BRY | Hot Stocks06:33 EDT Berry Corporation says production remains on track with prior guidance - The company continues to maintain ample liquidity and generate the free cash flow necessary to further reduce debt and fund shareholder returns as appropriate. Production remains on track with the company's previously issued annual guidance, and the company has in-hand the necessary permits to complete its planned drilling program for 2024, as well as to support activity into 2025. Based on its inventory of workovers, sidetracks, and new wells, and assuming permits continue to be issued at the rate and in the manner they are currently being issued, the company has line of sight to keep production flat and maintain free cash flow into 2026. "We remain focused on creating value by maintaining balance sheet strength and generating sustainable free cash flow. The second half of the year traditionally has significantly better free cash flow compared to the first half due to lower working capital usage. Our capital expenditures are expected to be well under cash flow from operations in the second half of 2024 and we are on track to meet our annual production goals," said Mike Helm, Berry's CFO. He continued, "Supported by our strong operations, we have and will continue to take steps to strengthen our financial position. For example, we reduced our revolver balance by 57% from the end of the first quarter to date. This reflects our continued prioritization of debt reduction, prudently investing in the business and returning capital to our shareholders when appropriate. We are actively looking to further strengthen our balance street, including the extension or refinancing of our RBL facility, and addressing our senior unsecured notes due February 2026."
|
| PALT CSCO | Hot Stocks06:04 EDT Paltalk awarded $65.7M jury verdict against Cisco Systems in patent suit - Paltalk (PALT) announced that a jury in the District Court for the Western District of Texas has awarded the company $65.7M in a verdict against Cisco Systems (CSCO) for infringing U.S. Patent No. 6,683,858. As previously disclosed, on July 23, 2021, Paltalk Holdings, Inc., a wholly owned subsidiary of the Company, filed a patent infringement lawsuit against Cisco in the U.S. District Court for the Western District of Texas, pursuant to which the company alleged that certain of Cisco's products infringed U.S. Patent No. 6,683,858, and that the company was entitled to damages. On August 29, 2024, the jury awarded the company $65.7M in a jury verdict in connection with the Lawsuit, which remains subject to post-trial proceedings and the entry of a final judgment by the Court. The exact amount of the Award proceeds to be received by the company will be determined based on a number of factors and will reflect the deduction of significant litigation-related expenses, including legal fees. Consequently, the company estimates that it would receive no more than one third of the gross proceeds in connection with the Award, subject to post-trial proceedings and the entry of a final judgment by the Court.
|
| ALNY | Hot Stocks06:02 EDT Alnylam announces results from HELIOS-B Phase 3 study of vutrisiran - Alnylam Pharmaceuticals announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy. The data were presented today in a Hot Line session at the European Society of Cardiology Congress 2024, taking place August 30-September 2 in London, United Kingdom. Results from the HELIOS-B study were also simultaneously published in The New England Journal of Medicine. As previously reported, the HELIOS-B study met all 10 of its primary and secondary endpoints, across both the overall and monotherapy populations, with statistical significance. Enrolled patients were predominantly New York Heart Association Class I or II with wild-type disease and had been diagnosed by non-invasive methods, with substantial concurrent treatment with available standard of care treatments such as tafamidis and SGLT2 inhibitors - reflecting the contemporary ATTR-CM patient population. In the study, treatment with vutrisiran substantially reduced the risk of death and cardiovascular events relative to placebo. In the overall population, vutrisiran reduced the risk of all-cause mortality and recurrent cardiovascular events by 28%, with similar reductions in both the mortality and cardiovascular events components of the endpoint. Mortality in this population was significantly reduced by 31% during the double-blind period and by 36% up to 42 months. In the monotherapy population, vutrisiran significantly reduced the risk of all-cause mortality and recurrent cardiovascular events by 33% and significantly reduced the risk of mortality by 35% up to 42 months. As a component of the primary endpoint, a non-significant reduction of 30% in mortality was observed in the monotherapy population during the double-blind period. Vutrisiran treatment was also associated with benefits versus placebo across multiple well-established clinical measures of disease progression, including 6-Minute Walk Test, Kansas City Cardiovascular Questionnaire, and NYHA Class, as well as the cardiac biomarker NT-proBNP. Subgroup analyses demonstrated consistent benefits across all key patient segments, including patients receiving background tafamidis. Trends toward greater efficacy were seen in patients with earlier disease. In HELIOS-B, the safety and tolerability profiles of vutrisiran were consistent with what had been established in the currently approved patient population, as well as earlier clinical studies.
|
| PPG | Hot Stocks05:44 EDT PPG expands operations in Malaysia, adds additional capacity - PPG announced that it has expanded operations in Petaling Jaya, Malaysia to include the production of non-stick coatings for kitchenware, industrial bakeware and low friction applications. The plant now has additional capacity to support growing regional coatings demand as well as increased space dedicated to valuable services for customers, including a state-of-the-art testing laboratory. The facility is now equipped with five new production lines for both waterborne and solventborne non-stick and low-friction coatings. This dual capability enables PPG to tailor solutions to meet a wide range of customer needs and product specifications. With a focus on sustainably advantaged coatings solutions, the Petaling Jaya plant will service customers in the energy sector. Additionally, non-stick and decorative coatings produced at the plant will offer customers in the kitchen and industrial bakeware industries - coatings options that are made without PFAS.
|
| HCM | Hot Stocks05:41 EDT Hutchmed withdraws NDA in China for fruquintinib in combination with paclitaxel - Hutchmed announced that it has voluntarily withdrawn its supplemental new drug application in China for fruquintinib in combination with paclitaxel for the treatment of second-line advanced gastric or gastroesophageal junction adenocarcinoma and will evaluate a new route forward. Following an additional internal review of the current data package, in light of recent discussions with the National Medical Products Administration of China, Hutchmed has determined that the submission is unlikely to support an approval in China at this time. This supplemental NDA for fruquintinib was based on data from the Phase III FRUTIGA study due to statistically significant improvements in many clinically meaningful endpoints, including progression-free survival, which served as one of two primary endpoints. However, while an improvement was also observed in the second primary endpoint of median overall survival, it was not statistically significant. Extensive subsequent analyses conducted indicate that, although the high and imbalanced proportion of patients receiving subsequent antitumor therapies confounded the OS effect, fruquintinib plus paclitaxel demonstrated meaningful clinical benefit and favorable OS trends through a variety of models. Furthermore, no new safety signals were observed, and fruquintinib plus paclitaxel showed a tolerable safety profile. However, it became clear from dialogue with the Centre for Drug Evaluation of the NMPA and its external committee members that the current understanding and interpretation of the OS results could not serve as the basis of the supplemental NDA approval, and that further work needs to be undertaken.
|
| MNSO | Hot Stocks05:23 EDT Miniso announces RMB 621M interim cash dividend - "Our capital allocation strategy will also continue to balance fast growth and our commitment to bring stable and foreseeable returns to shareholders. The Board of the Company has approved an interim cash dividend for the First Half of 2024, with a total amount of approximately RMB621 million. Upon the payment of the interim dividend, the Company will have returned RMB1.4 billion in cash to shareholders through dividends and share repurchases from year to date. Since 2020, we will have returned RMB3.6 billion to shareholders upon the payment of the interim dividend, accounting for 62% of adjusted net profit accumulated from 2020 until the First half of 2024. We are confident in accomplishing our full-year business plan and five-year strategy and believe that our share price has been trading below its intrinsic value. Accordingly, the Board of the Company has approved a share repurchase program to make the best of the general mandate granted at its annual general meeting held in June 2024, under which the Company may repurchase its shares and/or ADSs in the next 12 months not exceeding 10% of the total outstanding shares and execute share repurchases in the open market subject to market conditions. We believe that the share repurchase program is in the best interests of the Company and its shareholders as a whole and creates value for shareholders." Zhang concluded.
|
| MNSO | Hot Stocks05:10 EDT Miniso announces HKD 2B share repurchase program - Miniso announced that, the board of directors of the company authorized and approved a new share repurchase program on August 30, under which the company may repurchase up to HKD 2B in value of its outstanding ordinary shares and/or American depositary shares representing its ordinary shares over a period of 12 months starting from the approval date. The company expects to fund the repurchases under the 2024 share repurchase program from surplus cash on its balance sheet.
|
